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Abstract
Background: Relatively little is known about the role of specific saturated fatty acids in the development of high
fat diet induced obesity and insulin resistance. Here, we have studied the effect of stearate in high fat diets (45%
energy as fat) on whole body energy metabolism and tissue specific insulin sensitivity.
Methods: C57Bl/6 mice were fed a low stearate diet based on palm oil or one of two stearate rich diets, one diet
based on lard and one diet based on palm oil supplemented with tristearin (to the stearate level of the lard based
diet), for a period of 5 weeks. Ad libitum fed Oxidative metabolism was assessed by indirect calorimetry at week 5.
Changes in body mass and composition was assessed by DEXA scan analysis. Tissue specific insulin sensitivity was
assessed by hyperinsulinemic-euglycemic clamp analysis and Western blot at the end of week 5.
Results: Indirect calorimetry analysis revealed that high levels of dietary stearate resulted in lower caloric energy
expenditure characterized by lower oxidation of fatty acids. In agreement with this metabolic phenotype, mice on
the stearate rich diets gained more adipose tissue mass. Whole body and tissue specific insulin sensitivity was
assessed by hyperinsulinemic-euglycemic clamp and analysis of insulin induced PKBser473 phosphorylation. Whole
body insulin sensitivity was decreased by all high fat diets. However, while insulin-stimulated glucose uptake by
peripheral tissues was impaired by all high fat diets, hepatic insulin sensitivity was affected only by the stearate rich
diets. This tissue-specific pattern of reduced insulin sensitivity was confirmed by similar impairment in insulin-
induced phosphorylation of PKBser473 in both liver and skeletal muscle.
Conclusion: In C57Bl/6 mice, 5 weeks of a high fat diet rich in stearate induces a metabolic state favoring low
oxidative metabolism, increased adiposity and whole body insulin resistance characterized by severe hepatic insulin
resistance. These results indicate that dietary fatty acid composition per sé rather than dietary fat content
determines insulin sensitivity in liver of high fat fed C57Bl/6 mice.
Introduction
High fat diets are widely used to study the development
of obesity and insulin resistance in rodent models. The
fat used in these diets often derives from natural
sources, for example lard, tallow, palm oil or coca butter
which contain fatty acids varying in chain-length and
saturation level. Although different high fat diets clearly
induce different effects [1-3], it has been a challenge to
assign specific effects to individual fatty acids. This is
specifically of interest and relevance for differential
effects of the saturated long chain fatty acids (FA)
palmitic acid (C16:0) and stearic acid (C18:0), which
represent the most common nutritional long chain fatty
acids [4].
Differences in dietary FA composition are of physiolo-
gical relevance, since the metabolic fate of FA is depen-
dent on chain length as well as the degree of saturation.
For example, oxidative efficiency of FA decreases with
increasing chain length and saturation level. In rats,
after oral administration of labeled FA, the efficiency of
the oxidation of saturated FA has been demonstrated to
be lauric acid (C12:0) > myristic acid (C14:0) > palmitic
acid (C16:0) > stearic acid (C18:0) [5]. Similar results
have been found in a human study where the oxidation
rate of stearic acid after a bolus administration was
found to be poor in comparison to lauric acid (13%
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versus 41% oxidized within 9 hours after administration)
[6]. Accordingly, at the cellular level, stearic acid has
been described to be poorly oxidized by hepatocytes [7].
In addition to their low oxidative efficiency, saturated
long chain FA are known to affect insulin sensitivity
directly in a chain length dependent manner via a TLR4
dependent pathway [8-10].
In this study, we investigated whether the level of diet-
ary stearate in high fat diets determines whole-body
energy metabolism and tissue-specific insulin sensitivity.
For this purpose, mice were fed for 5 weeks either a diet
low in stearate or two diets naturally or artificially
enriched in stearate. Whole-body metabolism was
assessed by indirect calorimetry and body composition
analyzed by Dual Energy X-ray Absorptiometry (DEXA).
Tissue-specific insulin sensitivity was evaluated by both
hyperinsulinemic-euglycemic clamp and phosphorylation
of key proteins involved in the insulin signaling pathway.
Methods
Animals, diets and housing
All animal experiments were approved by the Animal
Ethic Committee from the Leiden University Medical
Center (Leiden, the Netherlands) in accordance with the
principles and guidelines established by the European
Convention for the Protection of Laboratory Animals.
Male C57Bl/6J mice were obtained from Charles River
Laboratories at an age of 8 weeks and acclimatized up
to an age of 12 weeks at the Leiden University Medical
Center animal facility. Animals were housed in a con-
trolled environment (23°C, 55% humidity) under a 12 h
light-dark cycle (07:00-19:00). Food and tap water was
available ad libitum during the whole experiment. After
acclimatization mice were switched to a low-fat run-in
diet (10% energy in the form of fat, D12450B, Research
Diet Services, Wijk bij Duurstede, The Netherlands) for
a period of 2 weeks, with fat sources consisting of palm
oil (LFW) or lard (LFL) matching the later experimental
high and low stearate high fat diets. The composition of
the low fat run in diets was similar to the high fat diets
in all respects apart from total fat content. At the age of
14 weeks, animals were randomized for body mass and
switched to the high fat experimental diets (24% w/w
protein, 41% w/w carbohydrate and 24% w/w fat with
45% energy in the form of fat, D12451, Research Diet
Services, Wijk bij Duurstede, The Netherlands) for a
period of 5 weeks. High fat diets are referred to as HFP
(palm oil, 4.4% of total fat content is stearate), HFL
(lard based diet, 15.0% of total fat is stearate) and HFPS
(palm oil + tristearin supplementation, 13.9% of total fat
is stearate) in this paper (table 1). After tristearin sup-
plementation, stearate content of the HFPS high fat diet
was comparable to the lard based high fat diet, whereas
the dilution of the other fatty acids was kept to a
minimum (2.3%) to avoid secondary effects due to
depletion of other fatty acids (table 2).
Indirect calorimetry
Groups of 8 mice per high fat diet were subjected to
individual indirect calorimetry measurements for a per-
iod of 4 consecutive days (Comprehensive Laboratory
Animal Monitoring System, Columbus Instruments,
Columbus Ohio, US). A period of 24 hours prior to the
start of the experiment allowed the acclimatization of
Table 1 Composition of HFP, HFL, HFPS high fat diets.
Diet composition
Ingredient grams
Casein, 80 Mesh 200 200 200
L-Cystine 3 3 3
Corn Starch 72.8 72.8 72.8
Maltodextrin 10 100 100 100
Sucrose 172.8 172.8 172.8
Cellulose, BW200 50 50 50
Soybean Oil 25 25 25
Palm oil 177.5 0 177.5
Tristearin 0 0 27.5
Lard 0 177.5 0
Mineral Mix S10026 10 10 10
DiCalcium Phosphate 13 13 13
Calcium Carbonate 5.5 5.5 5.5
Potassium Citrate, 1 H2O 16.5 16.5 16.5
Vitamin Mix V10001 10 10 10
Choline Bitartrate 2 2 2
FD&C Red Dye #40 0.05 0.05 0.05
total 858.15 858.15 885.65
Table 2 Fatty acid composition of HFP, HFL, HFPS. FA
levels are represented as percentage of total fat content.
Fatty acid composition (% of total):
HFP HFL HFPS
C12:0 0.3 - 0.3
C14:0 0.9 0.8 0.8
C16:0 35.6 29.2 32.0
C16:1w7 0.2 2.8 0.2
C18:0 4.4 15.0 13.9
C18:1w9 40.6 43.3 36.6
C18:2w6 16.5 8.9 14.8
C18:3w3 0.7 - 0.6
C20:0 0.5 - 0.5
C20:1w9 0.1 - 0.1
C22:0 0.2 - 0.2
Total % 100 100 100
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the animals to the cages and the single housing. Experi-
mental analysis started at 09:00 h and continued for 72
hours. Analyzed parameters included real time food and
water intake, as well as meal size, frequency and dura-
tion. Oxygen consumption (VO2) and carbon dioxide
production rates (VCO2) were measured at intervals of
7 minutes. Respiratory exchange ratio (RER) as a mea-
sure for metabolic substrate choice was calculated using
the following formula:
RER VCO2/VO2.
Carbohydrate and fat oxidation rates were calculated
from VO2 and VCO2 using the following formulas [11]:
Carbohydrate oxidation kcal/h 585*VCO2)-(3.226*VO2))*( ) (( . 4 4/1000
Fat oxidation(kcal/h) ((1.695*VO2)-(1.701*VCO2))*9/1 000
VO2 and VCO2 values are in mL/h. Total energy
expenditure was calculated from the sum of carbohy-
drate and fat oxidation. Activity was monitored as infra-
red beam breaks in both X and Y axis.
Body anthropometry and Dual Energy X-ray
Absorptiometry (DEXA) scan analysis
Animals were subjected to DEXA scan analysis in fed
conditions to avoid weight loss induced by overnight
fasting. Animals were weighed and sedated by a single
intra peritoneal injection of a mixture of Acepromazin
(0.5 mg/kg), Midazolam (0.25 mg/kg) and Fentanyl
(0.025 mg/kg). Sedated animals were scanned in toto
using a small animal DEXA scanner (pDEXA, Norland
Stratec Medizintechinik GmbH, Birkenfeld, Germany)
and data were analyzed by the software supplied by the
manufacturer. Fat mass and lean body mass were
determined.
Hyperinsulinemic euglycemic clamp experiments
Hyperinsulinemic - euglycemic clamp experiments were
performed as described before [12-16] with minor modi-
fications to fit our specific model. Per group 5-8 mice
were clamped. Clamp experiments were performed after
an overnight fast. Animals were anesthetized by ip injec-
tion with a combination of Acepromazin (0.5 mg/kg,
Sanofi Santé Nutrition Animale, Libourne Cedex,
France), Midazolam (0.25 mg/kg, Roche, Mijdrecht, The
Netherlands) and Fentanyl (0.025 mg/kg, Janssen-Cilag,
Tilburg, The Netherlands). An infusion needle was placed
into a tail vein. After 60 min infusion of D-[1-14C]-
glucose at a rate of 0.8 μCi/h (specific activity, 9.6
GBq/mmol; Amersham, Little Chalfont, UK) to achieve
steady-state levels and basal parameters were deter-
mined with 10-min intervals. Thereafter, a bolus of
insulin (4.5 mU, Actrapid; Novo Nordisk, Chartres,
France) was administered and the hyperinsulinemic
clamp was started. Insulin was infused at a constant
rate of 3.5 mU/kg.min, and D-[1-14C]glucose was
infused at a rate of 0.8 μCi/h. A variable infusion of
12.5% D-glucose (in PBS) was also started to maintain
euglycemic basal blood glucose levels. Blood glucose
was measured with an AccuCheck hand glucose mea-
surer (AccuCheck, Roche Diagnostics, Metronic Medi-
cal Systems, Vianen, The Netherlands) every 10 min to
monitor glucose levels and adjust the glucose pump.
After reaching steady state, blood samples were taken
at 10-min intervals during 30 min to determine steady-
state levels of [14C]glucose. An average clamp experi-
ment took approximately 2.5 h, and anesthesia as well
as body temperature was maintained throughout the
procedure. For time courses of the plasma glucose
levels and glucose infusion rates during the clamp are
shown (see additional file 1).
Analysis of clamp samples
Plasma insulin concentrations were measured by ELISA
(Mercodia, Sweden). To measure plasma [14C]glucose
activity, trichloroacetic acid (final concentration 2%) was
added to 7.5 μl plasma to precipitate proteins using cen-
trifugation. The supernatant was dried to remove water
and resuspended in milliQ. The samples were counted
using scintillation counting (Packard Instruments, Dow-
ers Grove, IL).
Calculations
The glucose turnover rate (μmol/min·kg) was calculated
during the basal period and under steady-state clamp
conditions as the rate of tracer infusion (dpm/min)
divided by the plasma specific activity of [14C]glucose
(dpm/μmol). The ratio was corrected for lean body
mass. The hyperinsulinemic hepatic glucose production
(HGP) was calculated as the difference between the
tracer-derived rate of glucose appearance and the glucose
infusion rate.
Insulin signalling experiments
Insulin signalling analysis was performed as described
before [17,18], with minor modifications to fit our speci-
fic model. Experiments were performed after overnight
fast, to mimic the physiological situation of the clamp
experiments. A total of 15 to 20 mice per intervention
group were used in this experiment. Each group was
divided in a control (PBS infusion) group and an insulin
group. All animals were sedated using a mixture of Ace-
promazin (0.5 mg/kg), Midazolam (0.25 mg/kg) and
Fentanyl (0.025 mg/kg). Custom made intravenous
occlusion canulas (27G * 3/4, BD Microlance) were
inserted in the tail vein and kept open by infusion of
PBS. PBS or insulin (0.25 mU/min) was administered
for a period of 15 minutes during the experiment.
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Co-infusion with glucose (1.73 umol/min) was per-
formed in concert with insulin to maintain euglycemia.
After the infusion animals were sacrificed by cervical
dislocation and liver and calf muscle were harvested and
snap frozen in liquid nitrogen as fast as possible. Insulin
stimulated phosphorylation of PKB at serine 473 was
measured and corrected for total PKB.
Western Blot analysis
Tissues were homogenized by Ultraturax in a 10:1 (v/w)
ratio of ice-cold buffer containing: 30 mM Tris.HCl (pH
7.5), 150 mM NaCl, 0.5% Triton X-100, 0.5% sodium
deoxycholate, 1% SDS, 1 mM Na3VO4, 10 mM NaF
and protease inhibitors cocktail (Complete Protease Inhi-
bitor Cocktail, Roche Nederland BV, Woeren, The
Netherlands). Homogenates were cleared by centrifuga-
tion (13.200 rpm; 15 min, 4°C) and the protein content
of the supernatant was determined using a BCA protein
assay kit (Thermo Fisher Scientific Inc, Rock-
ford, IL, USA) Samples were prepared in 2 ×
Laemmli buffer containing 100 mM dithiothreitol and
boiled in a water bath for 5 minutes. 20-50 mg of pro-
teins were separated on SDS-PAGE (7-10% gel) followed
by transfer to a PVDF membrane. Membranes were
blocked for 1 hour at room temperature in TBST 5%
non-fat dry milk followed by an overnight incubation
with the anti-phospho-Ser473-PKB, anti-PKB, anti-a-
actin (Cell signaling) or anti-GLUT4 (Abcam). Blots
were then incubated with an HRP-conjugated goat anti-
rabbit secondary antibody for 1 hour at room tempera-
ture. Bands were visualized by ECL and quantified using
Image J (NIH, USA).
Statistical analysis
All data derived from the experiments were analyzed
using the SPSS 15.0 package. DEXA scan data and indir-
ect calorimetry data was tested by one-way ANOVA for
normally distributed data followed by a Tukey’s multiple
comparison test between the HFP, HFL and HFPS
groups. Indirect calorimetry data was split into day and
night values for all respiratory parameters as well as
activity levels. Clamp data were generated in two experi-
ments; HFL versus HFP and HFPS versus HFP. CLAMP
data was analyzed per experiment using unpaired stu-
dent T-Test for normally distributed data. For graphical
representation, data was normalized to HFP. In all
graphs and tables, means ± SEM are given. Statistical
significance threshold was set at p < 0.05.
Results
The effect of dietary stearate on whole body energy
metabolism
To determine whether a high level of dietary stearate
induces changes in whole body substrate selection or
energy metabolism, three high fat diets were evaluated
(table 1): a low stearate diet based on palm oil (HFP,
containing 4.4% stearate) and two stearate rich diets
based on lard (HFL, containing 15.0% stearate) or the
palm oil diet supplemented with tristearin (HFPS, con-
taining 13.9% stearate).
Mice were fed the various diets for 5 weeks and sub-
jected to indirect calorimetry using automated metabolic
cages. The animals fed the stearate rich HFL and HFPS
diets exhibited significant lower energy expenditure
rates compared to animals fed the HFP diet (figure 1A).
The lower energy expenditure levels in HFL and HFPS
fed animals was associated with lower caloric energy
expenditure levels during both the diurnal and nocturnal
period of the day in HFL and HFPS fed animals (figure
1B). Activity levels did not differ between groups at any
part of the day (data not shown). These data indicate
that the lower energy expenditure levels were indepen-
dent of physical activity. The significant decrease in
accumulated energy expenditure was mainly due to a
significantly lower FA oxidation rate (figure 1C, D).
Nocturnal FA oxidation rate tended to be lower in HFL
fed animals compared to HFP fed animals, although this
failed to reach statistical significance (p = 0.08). Carbo-
hydrate oxidation was not different between groups, at
any time of the day (figure 1E, F). During the diurnal
period, RER values only differed significantly between
the HFL group and the HFP group, whereas nocturnal
values did not differ between groups (figure 1G, H).
This may be due to the large variation in absolute car-
bohydrate oxidation compared to absolute fat oxidation
within the HFP and HFPS groups. Since the RER repre-
sents a composite measure of carbohydrate and fat oxi-
dation, the variation in carbohydrate oxidation will also
affect variation in RER.
Accumulated food intake over a period of 2.5 days was
significantly higher in HFL fed animals but not HFPS
fed animals compared to HFP fed animals (HFL, 8.4 ±
0.7 g; HFPS, 8.3 ± 0.7 g and HFP 7.2 ± 0.8 g, respec-
tively, p = 0.02 for HFL versus HFP). These data show
that mice fed the stearate rich HFL and HFPS diets
have higher or equal caloric intake but lower caloric
expenditure compared to the low stearate HFP fed mice,
a metabolic state favoring fat deposition. Accumulated
fecal caloric content determined in HFP and HFPS fed
animals after the end of the metabolic cage experiment
did not differ significantly between groups (HFP, 7.0 ±
1.9 kcal, HFPS, 7.8 ± 2.8 kcal, p = 0.520). After 5 weeks
of high fat diet, total body mass was higher in HFL and
HFPS fed mice when compared to HFP fed mice (HFL,
37.0 ± 3.0 g, HFPS, 35.6 ± 2.9 g, HFP, 31.1 ± 2.3 g resp.,
p < 0.05). DEXA analysis revealed that this was due to a
significantly higher fat mass in HFL and HFPS fed mice
(HFL, 15.3 ± 2.8 g, HFPS, 14.3 ± 1.2 g, HFP, 9.9 ± 1.4 g
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Figure 1 Indirect calorimetry analyses. Comparison of diets HFP, HFL and HFPS N = 7-8 mice per group. Rates and averaged values of energy
expenditure (A, B), fatty acid oxidation (C, D), carbohydrate oxidation (E, F) and Respiratory Exchange Rates (G, H) over a period of 2.5 days and
2.5 nights. Night periods are indicated by the black bars on the x-axis of the line graphs. In the line graphs, solid black lines represent the HFP
group, solid grey lines the HFL group and the dotted grey lines the HFPS group. In the bar graphs, nocturnal versus diurnal averaged values are
indicted with, respectively, N and D. * = p < 0.05 for the comparison with the equivalent period of the day of HFP fed mice.
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resp., p < 0.05). Lean body mass did not differ signifi-
cantly between groups (data not shown). In addition,
bone mineral content and bone mineral density did not
differ between groups (data not shown). Taken together,
these data show that the metabolic state of mice fed the
stearate rich HFL and HFPS diets resulted in higher
adiposity when compared to low stearate HFP fed mice.
The effect of dietary stearate on insulin sensitivity
To determine whether the adverse effects of stearate on
whole body metabolism are associated with the dete-
rioration of tissue specific insulin sensitivity, hyperinsuli-
nemic euglycemic clamp analyses were performed.
Fasting plasma glucose levels did not differ signifi-
cantly between groups (HFL; 4.4 ± 0.4, HFP, 4.7 ± 0.7
and HFPS 4.0 ± 0.4 mmol/l). At the end of the hyperin-
sulinemic period, plasma glucose levels where somewhat
higher in the HFL group, but did not differ significantly
from HFP controls (HFL; 5.3 ± 0.5, HFP, 4.4 ± 0.8 and
HFPS 4.2 ± 0.3 mmol/l). Insulin levels did not differ
between the HFL and HFP groups at the start (HFL; 0.6
± 0.2, HFP, 0.8 ± 0.3 ng/mL) or at the end of the clamp
(HFL; 4.7 ± 1.7, HFP, 4.4 ± 0.8 ng/mL). Unfortunately,
due to experimental error, insulin levels could not be
determined in the HFP versus HFPS experiment. During
the hyperinsulinemic clamp, the steady-state glucose
infusion rate was significantly decreased in HFP, HFL
and HFPS fed mice compared to a historical reference
group of chow fed mice (Chow; 124.6 ± 25.4, HFP; 34.5
± 22.6, HFL; 35.1 ± 17.4 and HFPS; 46.5 ± 22.6 umol*-
min-1*kg-1, p < 0.05 for all groups compared to chow),
demonstrating that all high fat diets induce whole body
insulin resistance (supplemental figure 1b). Interestingly,
the ability of insulin to repress hepatic glucose produc-
tion was significantly decreased in HFL and HFPS fed
animals compared to HFP fed mice (figure 2). Insulin
mediated uptake of glucose by peripheral tissues was
lower in all high fat diet groups compared to chow con-
trols (figure 2). In addition, the ability of insulin to sti-
mulate the rate of disappearance of glucose was
significantly reduced in HFP fed animals compared to
HFL and HFPS fed animals, indicating aggravated insu-
lin resistance in peripheral tissues (figure 2). These data
show that despite a similar decrease in whole body insu-
lin sensitivity, the insulin resistance induced by the low
stearate HFP diet is characterized by peripheral insulin
resistance only. In contrast, the stearate rich HFL and
HFPS diets induce severe hepatic insulin resistance but
a relatively less severe peripheral insulin resistance.
To further investigate the stearate induced alterations
in tissue specific insulin sensitivity, insulin signaling was
examined in liver and skeletal muscle (calf muscle) from
Figure 2 Insulin sensitivity. Chow, HFP, HFL and HFPS fed mice were subjected to hyperinsulinemic-euglycemic clamp analysis. Shown are the
insulin sensitivity of the peripheral tissues and the liver. Peripheral insulin sensitivity was expressed as the percentage of increase of glucose
disappearance rate (Rd) during the hyperinsulinemic state compared to basal. Hepatic insulin sensitivity was expressed as the percentage of
repression of hepatic glucose production compared to basal. N = 5-8 per group. The chow data (checkered bars) were obtained in a separate
experiment and are shown for comparison. *; p < 0.05 compared to chow, $; p < 0.05 compared to HFP.
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mice subjected to a 15 min i.v. infusion of PBS (control)
or insulin. In liver, the insulin-induced stimulation of
PKBser473 phosphorylation was identical in chow and
low stearate HFP fed mice (3.3 ± 0.6 and 2.9 ± 0.4 fold,
respectively) but severely impaired in stearate-rich HFL
and HFPS fed mice (1.1 ± 0.1 and 1.1 ± 0.4 fold, respec-
tively; p < 0.01 and p < 0.05 compared to HFP fed mice)
(figure 3A). This is in agreement with the clamp data on
hepatic insulin sensitivity. In parallel, hepatic expression
of the insulin receptor b (IR-b), which mediates cellular
insulin action, tended to be decreased in livers from
mice fed stearate rich HFL and HFPS, although this did
not reach statistical significance (p = 0.11 and p = 0.13
in HFL and HFPS versus HFP, respectively) (figure 3B).
In skeletal muscle, the insulin induced stimulation of
PKBser473 phosphorylation was impaired to a similar
extent by all high fat diets compared to chow (2.8 ± 0.8,
1.9 ± 0.6, 1.8 ± 0.4 and 9.6 ± 3.0 fold for HFP, HFL,
HFPS and chow, respectively; p < 0.05), although no dif-
ferences could be detected between the high fat groups
(figure 4A). Similarly, total GLUT-4 content was
reduced in the high fat diet groups HFP and HFL com-
pared to chow (p = 0.03, p = 0.03 in HFP and HFL ver-
sus chow, respectively) and was reduced in HFPS,
although this did not reach statistical significance (p =
0.06). No differences could be detected between high fat
diet groups (p = 0.39 and p = 0.40 in HFL and HFPS
versus HFP, respectively). These data are in line with
the clamp results indicating severe impairment of per-
ipheral tissue insulin sensitivity by the high fat diets.
Discussion
In this study, we have addressed the role of stearate in
high fat diet induced obesity and insulin resistance. As
compared to the low stearate HFP diet, the HFL diet
naturally high in stearate as well as the HFPS diet exo-
genously enriched with stearate (table 1) resulted in
lower energy expenditure (figure 1). Energy expenditure
values were lower during both the active (nocturnal)
and inactive (diurnal) part of the day, indicating that the
lower energy expenditure was independent of activity.
The lower energy expenditure levels were characterized
by a lower fat oxidation. Food intake was either higher
(HFL) or similar (HFPS) compared to HFP fed mice.
Weight gain was higher in the HFL and HFPS fed ani-
mals as compared to HFP fed animals. These results
may be explained by a low oxidative efficiency of stearic
acid which, together with the differences in food intake,
may lead to changes in nutrient partitioning and subse-
quent storage of fat in white adipose tissue.
In addition to an adverse metabolic phenotype, high
dietary stearate levels decreased hepatic insulin sensitiv-
ity, characterized by a decreased repression of hepatic
glucose production (figure 2) and impaired induction of
hepatic PKBser473 phosphorylation by insulin (figure 3A).
Thus, high fat diets rich in stearate induce a metabolic
state favoring adipogenesis and hepatic insulin
resistance.
The low stearate HFP diet did not affect hepatic insu-
lin sensitivity as determined by clamp analysis and
quantification of insulin induced PKBser473 phosphoryla-
tion (figure 3, 4A). Addition of stearate to HFP in the
HFPS diet mimicked the effects of the high stearate
HFL diet on hepatic insulin sensitivity. Thus, stearate
enrichment of the HFP diet per se induced an adverse
metabolic phenotype and hepatic insulin resistance.
However, since the FA composition of HFPS and HFL
are not identical (table 1), we cannot exclude that other
FA’s or non fatty acid components of the HFL diet, in
addition to stearate, contributed to the induction of
hepatic insulin resistance in HFL fed animals. However,
although food intake was significantly higher in HFL fed
animals compared to HFP fed animals, no differences
were found between HFPS and HFP fed animals. This
indicates that the amount of stearate added to the diet
does not affect food intake, and thus, that the hepatic
insulin resistance found in the HFPS fed animals is
dependant of dietary fatty acid composition rather than
food intake.
Interestingly, the effects of high dietary stearate are in
line with the effects of deficiency for Elovl6, the gene
encoding the elongase that catalyzes the conversion of
palmitate to stearate [19]. Deficiency for Elovl6 pro-
tected high fat diet fed mice from hyperinsulinemia and
hyperglycemia but not obesity and steatosis. These data
underline that fatty acid composition rather than fat
content per se determines insulin sensitivity in liver.
All high fat diets decreased whole body insulin sensi-
tivity (figure 2). This was characterized by a significantly
reduced insulin stimulated uptake of glucose in periph-
eral tissues. Interestingly, insulin sensitivity of peripheral
tissues was significantly more affected in mice fed the
low stearate diet as compared to the two stearate rich
diets. Analysis of insulin induced phosphorylation of
PKBser473 in muscle confirmed that all high fat diets
induce peripheral insulin resistance (figure 4B). How-
ever, this analysis did not confirm a difference in per-
ipheral insulin sensitivity between the low stearate and
stearate rich diets. This discrepancy between the clamp
and the PKBser473 phosphorylation analyses in muscle
could be due to the differences in the sensitivity of each
method (whole body/steady state versus isolated tissue/
bolus injection). In addition, it is possible that the glu-
cose and insulin response of PKBser473 phosphorylation
follow different kinetics in response to a continuous
infusion and a bolus administration. Moreover, alterna-
tive mechanisms responsible for the induction of insulin
resistance could play a role in peripheral tissues.
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Figure 3 Insulin-induced phosphorylation of PKB and IR-b expression in liver. Chow, HFP, HFL and HFPS fed mice were subjected to
continuous PBS or insulin (0.25 mU/min) i.v. infusion for 15 min before organ collection. Extracts from livers were immunoblotted with anti-
phospho-Ser 473 (A) and anti-IRb antibodies (B). Total PKB and a-actin were used as loading controls, respectively. The results of densitometric
quantification are expressed in arbitrary units as the ratio over the chow group and are means ± SEM, n = 7-8. *,$ p < 0.05 compared with PBS
and chow, respectively.
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Figure 4 Insulin-induced phosphorylation of PKB and IR-b and GLUT4 expression in calf muscle. Chow, HFP, HFL and HFPS fed mice
were subjected to continuous PBS or insulin (0.25 mU/min) i.v. infusion for 15 min before organ collection. Extracts from calf skeletal muscle
were immunoblotted with anti-phospho-Ser 473 (A), and anti-GLUT4 antibodies (B). Total PKB and a-actin were used as loading controls,
respectively. The results of densitometric quantification are expressed in arbitrary units as the ratio over the chow group and are means ± SEM,
n = 7-8. *,$ p < 0.05 compared with PBS and chow, respectively.
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The mechanistic explanation for the induction of
hepatic insulin resistance by dietary stearate remains to
be determined. The higher food intake in the HFL fed
animals per sé may induce insulin resistance. However,
no differences in food intake were found between the
HFP and HFPS fed groups. As the only difference in
dietary composition between these groups is stearate,
these data indicate that the higher food intake in the
HFL fed group are due to other components than stea-
rate. In addition, these data indicate that stearate
induces hepatic insulin resistance independent of food
intake. In a number of studies, long chain saturated
fatty acids have been shown to induce insulin resistance
by activation of pathways involved in inflammation that
intersect with insulin resistance such as the Toll-like
receptor 4 mediated activation of NF-kB, as well as
hyperphosphorylation of protein kinases like mammalian
target of rapamycin (mTOR), c-jun N-terminal kinase
(JNK), and protein kinase C isoforms [20-22]. A sus-
tained activation of these signaling kinases has been
linked to abrogation of the activation of the PI3K-PKB/
Akt pathway by insulin by inducing inhibitory serine
phosphorylations on the insulin receptor and IRS1/2
[23]. The involvement of these pathways in the develop-
ment of insulin resistance in the various tissues is cur-
rently under investigation.
A second explanation could be that stearate has been
found to be poorly oxidized in isolated rat hepatocytes
compared to myristate (C14:0) and palmitate (C16:0)
[24]. Since stearate is also a poor substrate for the gen-
eration of triglycerides and subsequently VLDL synthesis
[25], this could lead to an increased level of hepatic
stearate and/or stearate derived intermediates such as
diacylglycerol [26]. Accumulation of these factors has
been linked to increased insulin resistance (reviewed in
[27]).
A third explanation for the stearate effect concerns
the role of saturated fatty acids in determining mem-
brane rigidity and fluidity. The FA saturation degree and
FA chain length as well as the relative abundance of
individual FA have been described to affect membrane
composition and rigidity/fluidity [28]. This is especially
true in tissues where FA represent a large proportion of
the membrane, such as the liver in which FA can make
up as much as 10% of the total membrane [29]. In vitro
modeling studies of artificial cholesterol/phospholipid
membranes reveal that, already at a low concentration,
stearate destabilizes membrane integrity by increasing
the rigidity [30]. The stearate rich diets HFL and HFPS
could thus affect hepatic membrane structure, which in
turn will affect insulin signal transduction across the
plasma membrane.
In conclusion, our findings clearly show that feeding
high fat diets rich in stearate for 5 weeks induces
hepatic insulin resistance and obesity. Unraveling the
mechanisms underlying the effect of stearate on the
liver and on the development of obesity is highly rele-
vant to the human, in particular given the high propor-
tion of stearate in the human diet.
Additional file 1: Time course of plasma glucose and glucose
infusion rate during hyperinsulinemic euglycemic clamp. Plasma
glucose levels and glucose infusion rates as recorded during the
hyperinsulinemic euglycemic clamp analysis.
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